The whale feed
Who just crossed 5%?
When anyone — family offices, activist funds, sovereign wealth, famous CEOs buying into other companies — crosses a 3–5% voting- rights threshold in an EU or UK listed company, they must disclose it within 2–4 trading days. A different signal from Article 19 PDMR filings — conviction across the table, not inside one.
Affiliate links — we may earn a referral fee if you sign up.
Matching filings
Showing 10 most recent| Filed | Filer | Company | Move | New % | Source |
|---|---|---|---|---|---|
| 2026-08-20 1w ago | 🇫🇷Bpifrance Participations | EXOSENS | disclosed | 7.22% | regulator → |
| 2026-08-20 1w ago | 🇫🇷Bpifrance Participations 1 , le seuil de 10% des droits de vote de la société EXOSENS et détenir indirectement, 3 677 453 actions EXOSENS représentant 5 962 713 droits de vote, soit 7,22% du capital e | EXOSENS | ↑ crossed above | 7.22% | regulator → |
| 2026-08-07 3w ago | 🇫🇷Unnamed Filer (EXOSENS) | EXOSENS | disclosed | — | regulator → |
| 2026-06-18 2mo ago | 🇫🇷Unnamed Filer (EXOSENS) | EXOSENS | disclosed | — | regulator → |
| 2026-05-07 3mo ago | 🇫🇷Unnamed Filer (EXOSENS) | EXOSENS | disclosed | — | regulator → |
| 2026-05-05 4mo ago | 🇫🇷Unnamed Filer (EXOSENS) | EXOSENS | disclosed | — | regulator → |
| 2026-04-10 4mo ago | 🇫🇷Unnamed Filer (EXOSENS) | EXOSENS | disclosed | — | regulator → |
| 2026-01-13 7mo ago | 🇫🇷Unnamed Filer (EXOSENS) | EXOSENS | disclosed | — | regulator → |
| 2026-01-13 7mo ago | 🇫🇷Unnamed Filer (EXOSENS) | EXOSENS | disclosed | — | regulator → |
| 2025-12-16 8mo ago | 🇫🇷Unnamed Filer (EXOSENS) | EXOSENS | disclosed | — | regulator → |
Why this signal matters
A CEO buying €1m of their own stock is confidence. A family office quietly accumulating 5% of a small listed industrial is conviction across the table — and often a leading indicator of an activist campaign, a take-private bid, a sovereign wealth allocation, or a cornerstone investment. Academic literature (Brav, Jiang, Kim 2010 on activism; Bebchuk et al 2013) consistently finds substantial outperformance in the months following 13D / equivalent filings in the US. Europe's Transparency Directive is the European equivalent.